It covers more biological pathways than any other current peptide stack - but the exact combination has no clinical evidence behind it
GIP receptor activation improves how the body processes and stores fat, enhances insulin sensitivity beyond what GLP-1 alone achieves, and appears to reduce the inflammatory signaling associated with excess adipose tissue
GHK-Cu is designed to bind to and deliver copper
alternative-therapies.com No large scale blinded dose ranging Phase II or efficacy Phase III RCTs have been published, and no comprehensive peer reviewed human pharmacokinetic (PK) profile (oral vs injection absorption, bioavailability, distribution, metabolism, excretion) is available
Some MPs have said, I would need some compelling evidence to agree to do this. As if being restricted to just 4 lifesaving, cheap, injections a year isnt compelling enough
Dont worry your healthcare provider is here to help, not to judge